InsidersTradesSigma
Track the Resverlogix Corp. share price and the full directors' dealings record of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the authority of SEDI. Market capitalisation: €34.4m. The latest transaction was disclosed on 9 July 2026 (56 - Grant of rights). Among the most active insiders: Cann, Aaron Bradley. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Resverlogix Corp. 是一家生物制药公司，专注于开发心血管和代谢疾病的治疗方法。该公司在 XTSE 上市。